化学科研者一站式服务平台


  • (2S)-2-((4-(((2,7-二甲基-4-氧代-1,4-二氢喹唑啉-6-基)甲基)(丙-2-炔基)氨基)-2-氟苯甲酰)氨基)-4-(1H-四唑-5-基)丁酸

    (1R,2S,5S)-3-[(2S)-2-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

化合物简介



基本信息

CAS:865466-24-6
中文别名
英文别名:narlaprevir;CS-0445;(1R,5S)-N-[1(S)-[2-(cyclopropylamino)-1,2-dioxoethyl]pentyl]-3-[2(S)-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(S)-carboxamide;(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;Narlaprevir (USAN/INN);
分子式:C36H61N5O7S
分子量:707.964
精确质量:707.429
Psa:186.21
Logp:6.4674

编号系统

UNII:2857LA2O07

物化性质

密度:1.21

安全信息

生产方法及用途

合成路线

  • 参考文献

    SCHERING CORPORATION; TRAVERSE, John; LEONG, William, W.; MILLER, Steven, P.; ALBANEZE-WALKER, Jennifer; HUNTER, Thomas, J.; WANG, Lijun; LIAO, Hongbiao; ARASAPPAN, Ashok; TRZASKA, Scott, T.; SMITH, Randi, M.; LEKHAL, Azzeddine; BOGEN, Stephane, L.; KONG, Jianshe; BENNETT, Frank; NJOROGE, F., George; POIRIER, Marc; KUO, Shen-Chun; CHEN, Yonggang; MATTHEWS, Kenneth S.; DEMONCHAUX, Patrice; FERREIRA, Amadeo Patent: WO2011/14494 A1, 2011 ; Location in patent: Page/Page column 46 ;

上游原料

下游产品

图谱

1H NMR : Predict


13C NMR : Predict


加载中...